Global Digital Biomarker Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected and measured by means of digital devices such as portables, wearables, implantables, or digestibles. The data collected are typically used to explain, influence, and/or predict health-related outcomes. Digital biomarkers also represent an opportunity to capture clinically meaningful, objective data.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Digital Biomarker market is projected to reach US$ 22360 million by 2028 from an estimated US$ 604.6 million in 2022, at a CAGR of 82.5% during 2023 and 2028.

Philips and Novartis are the top 2 companies in global digital biomarker market and account for over 15% of total market share. Geographically speaking, Europe holds about 45% of global market share, followed by North America with about 35% share. In terms of type, passive digital biomarker segment holds an important share of about 65%. In terms of application, clinical disease segment accounts for about 80% of the total share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Digital Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Digital Biomarker.

The Digital Biomarker market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Digital Biomarker market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Digital Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Philips

Johnson & Johnson

Pfizer

GE Healthcare

Novartis

Apple

Sanofi

GlaxoSmithKline

Bayer

Merck

Abbott Laboratories

Asahi Kasei

Biogen

Koneksa Health

Roche

Huma Therapeutics

Product Type Insights

Global markets are presented by Digital Biomarker type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Digital Biomarker are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Passive Digital Biomarker

Active Digital Biomarker

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Digital Biomarker market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Digital Biomarker market.

Clinical Disease

Daily Health

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Rest of Asia-Pacific

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Digital Biomarker market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Biomarker market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Digital Biomarker and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Digital Biomarker industry.

This report helps stakeholders to gain insights into which regions to target globally.

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Biomarker.

1.1 Digital Biomarker Product Introduction

1.2 Market by Type

1.2.1 Global Digital Biomarker Market Size Growth Rate by Type (2017 VS 2021 VS 2028)

1.2.2 Passive Digital Biomarker

1.2.3 Active Digital Biomarker

1.3 Market by Application

1.3.1 Global Digital Biomarker Market Size Growth Rate by Application (2017 VS 2021 VS 2028)

1.3.2 Clinical Disease

1.3.3 Daily Health

1.4 Study Objectives

1.5 Years Considered

2.1 Global Digital Biomarker Market Size Estimates and Forecasts

2.2 Digital Biomarker Market Size by Region: 2022 Versus 2028

2.2.1 Global Digital Biomarker Revenue by Region: 2017-2022

2.2.2 Global Digital Biomarker Revenue Forecast by Region (2023-2028)

2.2.3 Global Digital Biomarker Revenue Market Share by Region (2017-2028)

3.1 Global Digital Biomarker Revenue by Company (2017-2022)

3.2 Global Digital Biomarker Revenue Share by Company (2017-2022)

3.3 Competitive Landscape

3.3.1 Key Digital Biomarker Companies around the World: Ranking by Revenue

3.3.2 Global Digital Biomarker Market Concentration Ratio (CR5 and HHI) & (2017-2022)

3.3.3 Global Digital Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.4 Global Digital Biomarker Companies Headquarters & Product Type

3.4.1 Digital Biomarker Companies Headquarters

3.4.2 Global Digital Biomarker Companies Product & Service

3.4.3 Date of International Companies Enter into Digital Biomarker Market

3.5 Global Digital Biomarker Mergers & Acquisitions, Expansion Plans

4.1 Philips

4.1.1 Philips Corporation Information

4.1.2 Philips Description, Business Overview

4.1.3 Philips Digital Biomarker Products Offered

4.1.4 Philips Digital Biomarker Revenue and Gross Margin (2017-2022)

4.1.5 Philips Digital Biomarker Revenue by Product in 2021

4.1.6 Philips Digital Biomarker Revenue by Application in 2021

4.1.7 Philips Digital Biomarker Revenue by Geographic Area in 2021

4.1.8 Philips Recent Developments

4.2 Johnson & Johnson

4.2.1 Johnson & Johnson Corporation Information

4.2.2 Johnson & Johnson Description, Business Overview

4.2.3 Johnson & Johnson Digital Biomarker Products Offered

4.2.4 Johnson & Johnson Digital Biomarker Revenue and Gross Margin (2017-2022)

4.2.5 Johnson & Johnson Digital Biomarker Revenue by Product in 2021

4.2.6 Johnson & Johnson Digital Biomarker Revenue by Application in 2021

4.2.7 Johnson & Johnson Digital Biomarker Revenue by Geographic Area in 2021

4.2.8 Johnson & Johnson Recent Developments

4.3 Pfizer

4.3.1 Pfizer Corporation Information

4.3.2 Pfizer Description, Business Overview

4.3.3 Pfizer Digital Biomarker Products Offered

4.3.4 Pfizer Digital Biomarker Revenue and Gross Margin (2017-2022)

4.3.5 Pfizer Digital Biomarker Revenue by Product in 2021

4.3.6 Pfizer Digital Biomarker Revenue by Application in 2021

4.3.7 Pfizer Digital Biomarker Revenue by Geographic Area in 2021

4.3.8 Pfizer Recent Developments

4.4 GE Healthcare

4.4.1 GE Healthcare Corporation Information

4.4.2 GE Healthcare Description, Business Overview

4.4.3 GE Healthcare Digital Biomarker Products Offered

4.4.4 GE Healthcare Digital Biomarker Revenue and Gross Margin (2017-2022)

4.4.5 GE Healthcare Digital Biomarker Revenue by Product in 2021

4.4.6 GE Healthcare Digital Biomarker Revenue by Application in 2021

4.4.7 GE Healthcare Digital Biomarker Revenue by Geographic Area in 2021

4.4.8 GE Healthcare Recent Developments

4.5 Novartis

4.5.1 Novartis Corporation Information

4.5.2 Novartis Description, Business Overview

4.5.3 Novartis Digital Biomarker Products Offered

4.5.4 Novartis Digital Biomarker Revenue and Gross Margin (2017-2022)

4.5.5 Novartis Digital Biomarker Revenue by Product in 2021

4.5.6 Novartis Digital Biomarker Revenue by Application in 2021

4.5.7 Novartis Digital Biomarker Revenue by Geographic Area in 2021

4.5.8 Novartis Recent Developments

4.6 Apple

4.6.1 Apple Corporation Information

4.6.2 Apple Description, Business Overview

4.6.3 Apple Digital Biomarker Products Offered

4.6.4 Apple Digital Biomarker Revenue and Gross Margin (2017-2022)

4.6.5 Apple Digital Biomarker Revenue by Product in 2021

4.6.6 Apple Digital Biomarker Revenue by Application in 2021

4.6.7 Apple Digital Biomarker Revenue by Geographic Area in 2021

4.6.8 Apple Recent Development

4.7 Sanofi

4.7.1 Sanofi Corporation Information

4.7.2 Sanofi Description, Business Overview

4.7.3 Sanofi Digital Biomarker Products Offered

4.7.4 Sanofi Digital Biomarker Revenue and Gross Margin (2017-2022)

4.7.5 Sanofi Digital Biomarker Revenue by Product in 2021

4.7.6 Sanofi Digital Biomarker Revenue by Application in 2021

4.7.7 Sanofi Digital Biomarker Revenue by Geographic Area in 2021

4.7.8 Sanofi Recent Development

4.8 GlaxoSmithKline

4.8.1 GlaxoSmithKline Corporation Information

4.8.2 GlaxoSmithKline Description, Business Overview

4.8.3 GlaxoSmithKline Digital Biomarker Products Offered

4.8.4 GlaxoSmithKline Digital Biomarker Revenue and Gross Margin (2017-2022)

4.8.5 GlaxoSmithKline Digital Biomarker Revenue by Product in 2021

4.8.6 GlaxoSmithKline Digital Biomarker Revenue by Application in 2021

4.8.7 GlaxoSmithKline Digital Biomarker Revenue by Geographic Area in 2021

4.8.8 GlaxoSmithKline Recent Development

4.9 Bayer

4.9.1 Bayer Corporation Information

4.9.2 Bayer Description, Business Overview

4.9.3 Bayer Digital Biomarker Products Offered

4.9.4 Bayer Digital Biomarker Revenue and Gross Margin (2017-2022)

4.9.5 Bayer Digital Biomarker Revenue by Product in 2021

4.9.6 Bayer Digital Biomarker Revenue by Application in 2021

4.9.7 Bayer Digital Biomarker Revenue by Geographic Area in 2021

4.9.8 Bayer Recent Development

4.10 Merck

4.10.1 Merck Corporation Information

4.10.2 Merck Description, Business Overview

4.10.3 Merck Digital Biomarker Products Offered

4.10.4 Merck Digital Biomarker Revenue and Gross Margin (2017-2022)

4.10.5 Merck Digital Biomarker Revenue by Product in 2021

4.10.6 Merck Digital Biomarker Revenue by Application in 2021

4.10.7 Merck Digital Biomarker Revenue by Geographic Area in 2021

4.10.8 Merck Recent Development

4.11 Abbott Laboratories

4.11.1 Abbott Laboratories Corporation Information

4.11.2 Abbott Laboratories Description, Business Overview

4.11.3 Abbott Laboratories Digital Biomarker Products Offered

4.11.4 Abbott Laboratories Digital Biomarker Revenue and Gross Margin (2017-2022)

4.11.5 Abbott Laboratories Digital Biomarker Revenue by Product in 2021

4.11.6 Abbott Laboratories Digital Biomarker Revenue by Application in 2021

4.11.7 Abbott Laboratories Digital Biomarker Revenue by Geographic Area in 2021

4.11.8 Abbott Laboratories Recent Development

4.12 Asahi Kasei

4.12.1 Asahi Kasei Corporation Information

4.12.2 Asahi Kasei Description, Business Overview

4.12.3 Asahi Kasei Digital Biomarker Products Offered

4.12.4 Asahi Kasei Digital Biomarker Revenue and Gross Margin (2017-2022)

4.12.5 Asahi Kasei Digital Biomarker Revenue by Product in 2021

4.12.6 Asahi Kasei Digital Biomarker Revenue by Application in 2021

4.12.7 Asahi Kasei Digital Biomarker Revenue by Geographic Area in 2021

4.12.8 Asahi Kasei Recent Development

4.13 Biogen

4.13.1 Biogen Corporation Information

4.13.2 Biogen Description, Business Overview

4.13.3 Biogen Digital Biomarker Products Offered

4.13.4 Biogen Digital Biomarker Revenue and Gross Margin (2017-2022)

4.13.5 Biogen Digital Biomarker Revenue by Product in 2021

4.13.6 Biogen Digital Biomarker Revenue by Application in 2021

4.13.7 Biogen Digital Biomarker Revenue by Geographic Area in 2021

4.13.8 Biogen Recent Development

4.14 Koneksa Health

4.14.1 Koneksa Health Corporation Information

4.14.2 Koneksa Health Description, Business Overview

4.14.3 Koneksa Health Digital Biomarker Products Offered

4.14.4 Koneksa Health Digital Biomarker Revenue and Gross Margin (2017-2022)

4.14.5 Koneksa Health Digital Biomarker Revenue by Product in 2021

4.14.6 Koneksa Health Digital Biomarker Revenue by Application in 2021

4.14.7 Koneksa Health Digital Biomarker Revenue by Geographic Area in 2021

4.14.8 Koneksa Health Recent Development

4.15 Roche

4.15.1 Roche Corporation Information

4.15.2 Roche Description, Business Overview

4.15.3 Roche Digital Biomarker Products Offered

4.15.4 Roche Digital Biomarker Revenue and Gross Margin (2017-2022)

4.15.5 Roche Digital Biomarker Revenue by Product in 2021

4.15.6 Roche Digital Biomarker Revenue by Application in 2021

4.15.7 Roche Digital Biomarker Revenue by Geographic Area in 2021

4.15.8 Roche Recent Development

4.16 Huma Therapeutics

4.16.1 Huma Therapeutics Corporation Information

4.16.2 Huma Therapeutics Description, Business Overview

4.16.3 Huma Therapeutics Digital Biomarker Products Offered

4.16.4 Huma Therapeutics Digital Biomarker Revenue and Gross Margin (2017-2022)

4.16.5 Huma Therapeutics Digital Biomarker Revenue by Product in 2021

4.16.6 Huma Therapeutics Digital Biomarker Revenue by Application in 2021

4.16.7 Huma Therapeutics Digital Biomarker Revenue by Geographic Area in 2021

4.16.8 Huma Therapeutics Recent Development

5.1 Global Digital Biomarker Revenue by Type (2017-2022)

5.2 Global Digital Biomarker Revenue Forecast by Type (2023-2028)

5.3 Digital Biomarker Revenue Marke Share by Type (2017-2028)

6.1 Global Digital Biomarker Revenue by Application (2017-2022)

6.2 Global Digital Biomarker Revenue Forecast by Application (2023-2028)

6.3 Digital Biomarker Revenue Market Share by Application (2017-2028)

7.1 North America Digital Biomarker Market Size YoY Growth 2017-2028

7.2 North America Digital Biomarker Market Facts & Figures by Country (2017-2028)

7.3 North America Digital Biomarker Revenue by Type (2017-2022)

7.4 North America Digital Biomarker Revenue by Application (2017-2022)

8.1 Asia-Pacific Digital Biomarker Market Size YoY Growth 2017-2028

8.2 Asia-Pacific Digital Biomarker Market Facts & Figures by Region (2017-2028)

8.3 Asia-Pacific Digital Biomarker Revenue by Type (2017-2022)

8.4 Asia-Pacific Digital Biomarker Revenue by Application (2017-2022)

9.1 Europe Digital Biomarker Market Size YoY Growth 2017-2028

9.2 Europe Digital Biomarker Market Facts & Figures by Country (2017-2028)

9.3 Europe Digital Biomarker Revenue by Type (2017-2022)

9.4 Europe Digital Biomarker Revenue by Application (2017-2022)

10.1 Latin America Digital Biomarker Market Size YoY Growth 2017-2028

10.2 Latin America Digital Biomarker Market Facts & Figures by Country (2017-2028)

10.3 Latin America Digital Biomarker Revenue by Type (2017-2022)

10.4 Latin America Digital Biomarker Revenue by Application (2017-2022)

11.1 Middle East and Africa Digital Biomarker Market Size YoY Growth 2017-2028

11.2 Middle East and Africa Digital Biomarker Market Facts & Figures by Country (2017-2028)

11.3 Middle East and Africa Digital Biomarker Revenue by Type (2017-2022)

11.4 Middle East and Africa Digital Biomarker Revenue by Application (2017-2022)

12.1 Digital Biomarker Supply Chain Analysis

12.2 Digital Biomarker Key Raw Materials and Upstream Suppliers

12.3 Digital Biomarker Clients Analysis

12.4 Digital Biomarker Sales Channel and Sales Model Analysis

12.4.1 Digital Biomarker Distribution Channel Analysis: Indirect Sales VS Direct Sales

12.4.2 Digital Biomarker Distribution Channel Analysis: Online Sales VS Offline Sales

12.4.3 Digital Biomarker Distributors

13.1 Digital Biomarker Industry Trends

13.2 Digital Biomarker Market Drivers

13.3 Digital Biomarker Market Challenges

13.4 Digital Biomarker Market Restraints

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

List of Tables

    Table 1. Global Digital Biomarker Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028

    Table 2. Major Companies of Passive Digital Biomarker

    Table 3. Major Companies of Active Digital Biomarker

    Table 4. Global Digital Biomarker Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028

    Table 5. Global Digital Biomarker Market Size by Region (US$ Million): 2022 VS 2028

    Table 6. Global Digital Biomarker Revenue by Region (2017-2022) & (US$ Million)

    Table 7. Global Digital Biomarker Revenue Forecast by Region (2023-2028) & (US$ Million)

    Table 8. Digital Biomarker Revenue by Company (2017-2022) & (US$ Million)

    Table 9. Digital Biomarker Revenue Share by Company (2017-2022)

    Table 10. Ranking of Global Top Digital Biomarker Players by Revenue (US$ Million) in 2021

    Table 11. Global Digital Biomarker Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)

    Table 12. Global Digital Biomarker by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Digital Biomarker as of 2021)

    Table 13. Global Digital Biomarker Companies Headquarters

    Table 14. Global Digital Biomarker Companies Product & Service

    Table 15. Date of International Companies Enter into Digital Biomarker Market

    Table 16. Global Digital Biomarker Mergers & Acquisitions, Expansion Plans

    Table 17. Philips Corporation Information

    Table 18. Philips Description and Business Overview

    Table 19. Philips Digital Biomarker Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 20. Philips Digital Biomarker Product

    Table 21. Philips Digital Biomarker Revenue Proportion of Digital Biomarker by Product in 2021

    Table 22. Philips Digital Biomarker Revenue Proportion of Digital Biomarker by Application in 2021

    Table 23. Philips Digital Biomarker Revenue Proportion of Digital Biomarker by Geographic Area in 2021

    Table 24. Philips Recent Development

    Table 25. Johnson & Johnson Corporation Information

    Table 26. Johnson & Johnson Description and Business Overview

    Table 27. Johnson & Johnson Digital Biomarker Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 28. Johnson & Johnson Digital Biomarker Product

    Table 29. Johnson & Johnson Digital Biomarker Revenue Proportion of Digital Biomarker by Product in 2021

    Table 30. Johnson & Johnson Digital Biomarker Revenue Proportion of Digital Biomarker by Application in 2021

    Table 31. Johnson & Johnson Digital Biomarker Revenue Proportion of Digital Biomarker by Geographic Area in 2021

    Table 32. Johnson & Johnson Recent Development

    Table 33. Pfizer Corporation Information

    Table 34. Pfizer Description and Business Overview

    Table 35. Pfizer Digital Biomarker Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 36. Pfizer Digital Biomarker Product

    Table 37. Pfizer Digital Biomarker Revenue Proportion of Digital Biomarker by Product in 2021

    Table 38. Pfizer Digital Biomarker Revenue Proportion of Digital Biomarker by Application in 2021

    Table 39. Pfizer Digital Biomarker Revenue Proportion of Digital Biomarker by Geographic Area in 2021

    Table 40. Pfizer Recent Development

    Table 41. GE Healthcare Corporation Information

    Table 42. GE Healthcare Description and Business Overview

    Table 43. GE Healthcare Digital Biomarker Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 44. GE Healthcare Digital Biomarker Product

    Table 45. GE Healthcare Digital Biomarker Revenue Proportion of Digital Biomarker by Product in 2021

    Table 46. GE Healthcare Digital Biomarker Revenue Proportion of Digital Biomarker by Application in 2021

    Table 47. GE Healthcare Digital Biomarker Revenue Proportion of Digital Biomarker by Geographic Area in 2021

    Table 48. GE Healthcare Recent Development

    Table 49. Novartis Corporation Information

    Table 50. Novartis Description and Business Overview

    Table 51. Novartis Digital Biomarker Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 52. Novartis Digital Biomarker Product

    Table 53. Novartis Digital Biomarker Revenue Proportion of Digital Biomarker by Product in 2021

    Table 54. Novartis Digital Biomarker Revenue Proportion of Digital Biomarker by Application in 2021

    Table 55. Novartis Digital Biomarker Revenue Proportion of Digital Biomarker by Geographic Area in 2021

    Table 56. Novartis Recent Development

    Table 57. Apple Corporation Information

    Table 58. Apple Description and Business Overview

    Table 59. Apple Digital Biomarker Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 60. Apple Digital Biomarker Product

    Table 61. Apple Digital Biomarker Revenue Proportion of Digital Biomarker by Product in 2021

    Table 62. Apple Digital Biomarker Revenue Proportion of Digital Biomarker by Application in 2021

    Table 63. Apple Digital Biomarker Revenue Proportion of Digital Biomarker by Geographic Area in 2021

    Table 64. Sanofi Corporation Information

    Table 65. Sanofi Description and Business Overview

    Table 66. Sanofi Digital Biomarker Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 67. Sanofi Digital Biomarker Product

    Table 68. Sanofi Digital Biomarker Revenue Proportion of Digital Biomarker by Product in 2021

    Table 69. Sanofi Digital Biomarker Revenue Proportion of Digital Biomarker by Application in 2021

    Table 70. Sanofi Digital Biomarker Revenue Proportion of Digital Biomarker by Geographic Area in 2021

    Table 71. GlaxoSmithKline Corporation Information

    Table 72. GlaxoSmithKline Description and Business Overview

    Table 73. GlaxoSmithKline Digital Biomarker Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 74. GlaxoSmithKline Digital Biomarker Product

    Table 75. GlaxoSmithKline Digital Biomarker Revenue Proportion of Digital Biomarker by Product in 2021

    Table 76. GlaxoSmithKline Digital Biomarker Revenue Proportion of Digital Biomarker by Application in 2021

    Table 77. GlaxoSmithKline Digital Biomarker Revenue Proportion of Digital Biomarker by Geographic Area in 2021

    Table 78. Bayer Corporation Information

    Table 79. Bayer Description and Business Overview

    Table 80. Bayer Digital Biomarker Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 81. Bayer Digital Biomarker Product

    Table 82. Bayer Digital Biomarker Revenue Proportion of Digital Biomarker by Product in 2021

    Table 83. Bayer Digital Biomarker Revenue Proportion of Digital Biomarker by Application in 2021

    Table 84. Bayer Digital Biomarker Revenue Proportion of Digital Biomarker by Geographic Area in 2021

    Table 85. Merck Corporation Information

    Table 86. Merck Description and Business Overview

    Table 87. Merck Digital Biomarker Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 88. Merck Digital Biomarker Product

    Table 89. Merck Digital Biomarker Revenue Proportion of Digital Biomarker by Product in 2021

    Table 90. Merck Digital Biomarker Revenue Proportion of Digital Biomarker by Application in 2021

    Table 91. Merck Digital Biomarker Revenue Proportion of Digital Biomarker by Geographic Area in 2021

    Table 92. Abbott Laboratories Corporation Information

    Table 93. Abbott Laboratories Description and Business Overview

    Table 94. Abbott Laboratories Digital Biomarker Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 95. Abbott Laboratories Digital Biomarker Product

    Table 96. Abbott Laboratories Digital Biomarker Revenue Proportion of Digital Biomarker by Product in 2021

    Table 97. Abbott Laboratories Digital Biomarker Revenue Proportion of Digital Biomarker by Application in 2021

    Table 98. Abbott Laboratories Digital Biomarker Revenue Proportion of Digital Biomarker by Geographic Area in 2021

    Table 99. Asahi Kasei Corporation Information

    Table 100. Asahi Kasei Description and Business Overview

    Table 101. Asahi Kasei Digital Biomarker Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 102. Asahi Kasei Digital Biomarker Product

    Table 103. Asahi Kasei Digital Biomarker Revenue Proportion of Digital Biomarker by Product in 2021

    Table 104. Asahi Kasei Digital Biomarker Revenue Proportion of Digital Biomarker by Application in 2021

    Table 105. Asahi Kasei Digital Biomarker Revenue Proportion of Digital Biomarker by Geographic Area in 2021

    Table 106. Biogen Corporation Information

    Table 107. Biogen Description and Business Overview

    Table 108. Biogen Digital Biomarker Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 109. Biogen Digital Biomarker Product

    Table 110. Biogen Digital Biomarker Revenue Proportion of Digital Biomarker by Product in 2021

    Table 111. Biogen Digital Biomarker Revenue Proportion of Digital Biomarker by Application in 2021

    Table 112. Biogen Digital Biomarker Revenue Proportion of Digital Biomarker by Geographic Area in 2021

    Table 113. Koneksa Health Corporation Information

    Table 114. Koneksa Health Description and Business Overview

    Table 115. Koneksa Health Digital Biomarker Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 116. Koneksa Health Digital Biomarker Product

    Table 117. Koneksa Health Digital Biomarker Revenue Proportion of Digital Biomarker by Product in 2021

    Table 118. Koneksa Health Digital Biomarker Revenue Proportion of Digital Biomarker by Application in 2021

    Table 119. Koneksa Health Digital Biomarker Revenue Proportion of Digital Biomarker by Geographic Area in 2021

    Table 120. Roche Corporation Information

    Table 121. Roche Description and Business Overview

    Table 122. Roche Digital Biomarker Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 123. Roche Digital Biomarker Product

    Table 124. Roche Digital Biomarker Revenue Proportion of Digital Biomarker by Product in 2021

    Table 125. Roche Digital Biomarker Revenue Proportion of Digital Biomarker by Application in 2021

    Table 126. Roche Digital Biomarker Revenue Proportion of Digital Biomarker by Geographic Area in 2021

    Table 127. Huma Therapeutics Corporation Information

    Table 128. Huma Therapeutics Description and Business Overview

    Table 129. Huma Therapeutics Digital Biomarker Revenue (US$ Million) and Gross Margin (2017-2022)

    Table 130. Huma Therapeutics Digital Biomarker Product

    Table 131. Huma Therapeutics Digital Biomarker Revenue Proportion of Digital Biomarker by Product in 2021

    Table 132. Huma Therapeutics Digital Biomarker Revenue Proportion of Digital Biomarker by Application in 2021

    Table 133. Huma Therapeutics Digital Biomarker Revenue Proportion of Digital Biomarker by Geographic Area in 2021

    Table 134. Global Digital Biomarker Revenue by Type (2017-2022) & (US$ Million)

    Table 135. Global Digital Biomarker Revenue by Application (2017-2022) & (US$ Million)

    Table 136. Global Digital Biomarker Revenue Forecast by Application (2023-2028) & (US$ Million)

    Table 137. North America Digital Biomarker Revenue by Country (2017-2022) & (US$ Million)

    Table 138. North America Digital Biomarker Revenue by Country (2023-2028) & (US$ Million)

    Table 139. North America Digital Biomarker Revenue by Type (2017-2022) & (US$ Million)

    Table 140. North America Digital Biomarker Revenue by Application (2017-2022) & (US$ Million)

    Table 141. Asia-Pacific Digital Biomarker Revenue by Region (2017-2028) & (US$ Million)

    Table 142. Asia-Pacific Digital Biomarker Revenue by Region (2023-2028) & (US$ Million)

    Table 143. Asia-Pacific Digital Biomarker Revenue by Type (2017-2022) & (US$ Million)

    Table 144. Asia-Pacific Digital Biomarker Revenue by Application (2017-2022) & (US$ Million)

    Table 145. Europe Digital Biomarker Revenue by Country (2017-2022) & (US$ Million)

    Table 146. Europe Digital Biomarker Revenue by Country (2023-2028) & (US$ Million)

    Table 147. Europe Digital Biomarker Revenue by Type (2017-2022) & (US$ Million)

    Table 148. Europe Digital Biomarker Revenue by Application (2017-2022) & (US$ Million)

    Table 149. Latin America Digital Biomarker Revenue by Country (2017-2022) & (US$ Million)

    Table 150. Latin America Digital Biomarker Revenue by Country (2023-2028) & (US$ Million)

    Table 151. Latin America Digital Biomarker Revenue by Type (2017-2022) & (US$ Million)

    Table 152. Latin America Digital Biomarker Revenue by Application (2017-2022) & (US$ Million)

    Table 153. Middle East and Africa Digital Biomarker Revenue by Country (2017-2022) & (US$ Million)

    Table 154. Middle East and Africa Digital Biomarker Revenue by Country (2023-2028) & (US$ Million)

    Table 155. Middle East and Africa Digital Biomarker Revenue by Type (2017-2022) & (US$ Million)

    Table 156. Middle East and Africa Digital Biomarker Revenue by Application (2017-2022) & (US$ Million)

    Table 157. Digital Biomarker Key Raw Materials, Industry Status and Trend

    Table 158. Digital Biomarker Key Raw Materials and Upstream Suppliers

    Table 159. Digital Biomarker Clients Status and Trend

    Table 160. Digital Biomarker Typical Clients

    Table 161. Digital Biomarker Distributors

    Table 162. Digital Biomarker Market Trends

    Table 163. Digital Biomarker Market Drivers

    Table 164. Digital Biomarker Market Challenges

    Table 165. Digital Biomarker Market Restraints

    Table 166. Research Programs/Design for This Report

    Table 167. Key Data Information from Secondary Sources

    Table 168. Key Data Information from Primary Sources

List of Figures

    Figure 1. Digital Biomarker Product Picture

    Figure 2. Global Digital Biomarker Revenue Market Share by Type in 2021 & 2028

    Figure 3. Passive Digital Biomarker Product Picture

    Figure 4. Active Digital Biomarker Product Picture

    Figure 5. Global Digital Biomarker Revenue Market Share by Application in 2021 & 2028

    Figure 6. Clinical Disease

    Figure 7. Daily Health

    Figure 8. Digital Biomarker Report Years Considered

    Figure 9. Global Digital Biomarker Revenue, (US$ Million), 2017 VS 2021 VS 2028

    Figure 10. Global Digital Biomarker Market Size 2017-2028 (US$ Million)

    Figure 11. Global Digital Biomarker Market Size Market Share by Region: 2022 Versus 2028

    Figure 12. Global Digital Biomarker Revenue Market Share by Region (2017-2028)

    Figure 13. Digital Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

    Figure 14. Global Digital Biomarker Revenue Market Share Forecast by Type (2017-2028)

    Figure 15. Global Digital Biomarker Revenue Market Share Forecast by Application (2017-2028)

    Figure 16. North America Digital Biomarker Revenue 2017-2028 (US$ Million)

    Figure 17. North America Digital Biomarker Revenue Market Share by Type (2017-2022)

    Figure 18. North America Digital Biomarker Revenue Market Share by Application (2017-2022)

    Figure 19. Asia-Pacific Digital Biomarker Revenue 2017-2028 (US$ Million)

    Figure 20. Asia-Pacific Digital Biomarker Revenue Market Share by Region (2017-2028)

    Figure 21. Asia-Pacific Digital Biomarker Revenue Market Share by Type (2017-2022)

    Figure 22. Asia-Pacific Digital Biomarker Revenue Market Share by Application (2017-2022)

    Figure 23. Europe Digital Biomarker Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 24. Europe Digital Biomarker Revenue Market Share by Country (2017-2028)

    Figure 25. Europe Digital Biomarker Revenue Market Share by Type (2017-2022)

    Figure 26. Europe Digital Biomarker Revenue Market Share by Application (2017-2022)

    Figure 27. Latin America Digital Biomarker Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 28. Latin America Digital Biomarker Revenue Market Share by Country (2017-2022)

    Figure 29. Latin America Digital Biomarker Revenue Market Share by Type (2017-2022)

    Figure 30. Latin America Digital Biomarker Revenue Market Share by Application (2017-2022)

    Figure 31. Middle East and Africa Digital Biomarker Revenue Growth Rate 2017-2028 (US$ Million)

    Figure 32. Middle East and Africa Digital Biomarker Revenue Market Share by Country (2017-2028)

    Figure 33. Middle East and Africa Digital Biomarker Revenue Market Share by Type (2017-2022)

    Figure 34. Middle East and Africa Digital Biomarker Revenue Market Share by Application (2017-2022)

    Figure 35. Digital Biomarker Supply Chain (Upstream and Downstream Market)

    Figure 36. Global Production Market Share of Digital Biomarker Raw Materials by Region in 2021

    Figure 37. Digital Biomarker Distribution Channels

    Figure 38. Global Digital Biomarker Percentage 2017-2028: Indirect Sales VS Direct Sales

    Figure 39. Global Digital Biomarker Percentage 2017-2028: Online Sales VS Offline Sales

    Figure 40. Bottom-up and Top-down Approaches for This Report

    Figure 41. Data Triangulation

    Figure 42. Key Executives Interviewed